Alpha Tau Medical (NASDAQ:DRTSW) Trading 10.7% Higher

Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW) rose 10.7% on Thursday . The company traded as high as $0.23 and last traded at $0.23. Approximately 1,200 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 7,663 shares. The stock had previously closed at $0.21.

Alpha Tau Medical Price Performance

The business has a 50 day simple moving average of $0.26 and a two-hundred day simple moving average of $0.26.

Hedge Funds Weigh In On Alpha Tau Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. purchased a new position in Alpha Tau Medical in the first quarter valued at about $42,000. Chicago Partners Investment Group LLC purchased a new position in Alpha Tau Medical in the first quarter valued at about $55,000. Jane Street Group LLC purchased a new stake in shares of Alpha Tau Medical during the first quarter worth about $64,000. Walleye Trading LLC acquired a new stake in shares of Alpha Tau Medical during the first quarter worth about $65,000. Finally, Walleye Capital LLC lifted its holdings in Alpha Tau Medical by 10.9% in the second quarter. Walleye Capital LLC now owns 204,285 shares of the company’s stock valued at $98,000 after acquiring an additional 20,096 shares during the period.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.